IRIDEX Expands Retinal Portfolio

IRIDEX Corporation

announced today that it will introduce its new family of patented Adjustable & Intuitive Extended Reach (A&I XR) laser probes at the annual meeting of the American Academy of Ophthalmology to be held October 18 - 21 at McCormick Place in Chicago. The A&I XR laser probes are used for laser photocoagulation during vitreoretinal procedures. These new devices offer unprecedented uniformity and consistency of treatment using both straight and angled configurations that allow the surgeon to comfortably reach all parts of the anatomy. Vitreoretinal procedures include the management of a variety of conditions that affect the vitreous and retina that lie on the back part of the eye, such as diabetic retinopathy, macular degeneration, retinal detachments or tears and macular holes. Dr. Sam Mansour, Medical Director of Virginia Retina Center in Warrenton, VA, and Clinical Professor of Ophthalmology at The George Washington University in Washington, DC, commented, "Using the A&I XR probe, I was able to reach the full periphery of the eye. Its narrow cone angle allowed me to treat with lower power and further from the retina than with other laser probes. This results in enhanced physician visualization and improves patient safety." The A&I XR laser probes are available in 20-, 23-, and 25-gauge models with the option of finger or thumb actuators to smoothly guide the extension and retraction of the laser fiber. "Our new devices further enhance our robust line of premium laser probes, and amplifies our efforts to quickly design and launch consumable products to further grow our procedural based recurring revenues," said Will Moore, IRIDEX President and CEO.